Kim Hawkins

Global Head CSO Project Leaders Sanofi

Kim has 25 years of operational experience managing all phases of the drug development process. Kim started her career at Boston Medical Center as a Research Assistant working on pediatric AIDS and Oncology trials. After working in academia, she moved into industry and held various clinical operations positions at Boston-area biotechnology/pharmaceutical companies including Genzyme, Antigenics, and Novelos Therapeutics where she was the Vice President of Clinical Development. Kim joined Sanofi 7 years ago and is the Global Head of the Project Leader group within clinical operations. Additionally, Kim has taken a lead role in the implementation of decentralized clinical trials at Sanofi.

Kim is a graduate of Boston University with a Bachelor’s degree in Human Physiology and a Master’s degree in Public Health.

Clinical Trial Design Agenda

Thursday, December 10th, 2020

12:30 PM PANEL DISCUSSION: VIRTUAL, DECENTRALISED AND HYBRID CLINICAL TRIALS IN LIGHT OF THE CURRENT PANDEMIC

  • How is the industry reacting to this shift in leveraging remote strategies?
  • How do we balance key factors such as patient centricity, data, regulation, compliance and cost, and should flexibility be the greatest priority?
  • What impact is this having on the regulators and how they operate?
  • Will remote trials affect data endpoints and to what extent?
  • What impact do virtual, decentralised and hybrid trials have on patients and how can we reduce potential burdens?
  • How is this influencing patient engagement strategies?